Analyst David Rescott works at TRUIST and is focused on the Healthcare sector with 69 price targets and ratings documented since 2020 spanning on 6 stocks. Analyst's average stock valuation to be materialised ratio is 37.37% with an average time for price targets to be met of 101.4 days.
Most recent stock forecast was given on AXNX, Axonics Modulation Technologies, Inc at 20-Dec-2022.
David Rescott best performing recommendations are on IRTC (IRHYTHM TECHNOLOGIES, INC).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES, INC) at 5/8/2020. The price target of $130 was fulfilled within 3 days with a profit of $5.48 (4.4%) receiving and performance score of 14.67.
Average potential price target upside
Currently, out of the existing stock ratings of David Rescott - 2769 which are a Buy (73.76%), 985 which are a Hold (26.24%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
95
$15.36 (19.29%)
100
2 months 4 days ago
0/2 (0%)
$15.72 (19.20%)
Buy
89
$9.36 (11.75%)
102
2 months 19 days ago
0/5 (0%)
$23.28 (25.76%)
Hold
85
$5.36 (6.73%)
90
4 months 3 days ago
16/23 (69.57%)
$21.85 (24.76%)
619
Hold
84
$4.36 (5.47%)
89
4 months 5 days ago
7/13 (53.85%)
$12.47 (13.10%)
204
85
$5.36 (6.73%)
126
4 months 5 days ago
21/27 (77.78%)
$21.14 (30.70%)
578
